-
Spero Therapeutics' (SPRO) Overweight Rating Reaffirmed at Cantor Fitzgerald
Source: Buzz FX / 15 Nov 2024 11:21:18 America/New_York
Spero Therapeutics' (SPRO) Overweight Rating Reaffirmed at Cantor Fitzgerald Written by MarketBeat November 15, 2024 Share Link copied to clipboard. Spero Therapeutics ( NASDAQ:SPRO - Get Free Report ) 's stock had its "overweight" rating r
Read more...